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ScienceDirectG protein-coupled receptors (GPCRs) are an extensive class of
trans-plasma membrane proteins that function to regulate a
wide range of physiological functions. Despite a general
perception that GPCRs exist as monomers an extensive
literature has examined whether GPCRs can also form dimers
and even higher-order oligomers, and if such organization
influences various aspects of GPCR function, including cellular
trafficking, ligand binding, G protein coupling and signalling.
Here we focus on recent studies that employ approaches
ranging from computational methods to single molecule
tracking and both quantal brightness and fluorescence
fluctuation measurements to assess the organization, stability
and potential functional significance of dimers and oligomers
within the class A, rhodopsin-like GPCR family.
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Introduction
The human genome encodes more than 800 seven trans-
membrane-domain, G protein-coupled receptors
(GPCRs). In recent years enormous advances in structural
information on GPCRs have emerged in parallel with
methods to stabilize these proteins when they are
extracted from cellular membranes. Despite this, one
area that has remained uncertain is the quaternary orga-
nization of these proteins in their native environment [1–
2]. The numerically predominant rhodopsin-like, or Class
A, GPCRs are generally described as monomers. How-
ever, evidence emerging from a broad range of
approaches has shown that they can form both dimers
and higher-order oligomers with protomers of either the
same receptor (homo-dimers/oligomers) or with partners
of the same sub family and even with GPCRs which
respond to different ligands (hetero-dimers/oligomers).Current Opinion in Cell Biology 2019, 57:40–47 Homo-oligomerization of class A GPCRs
There is still significant debate about the functional
significance, the molecular basis of, the extent, and even
the existence [3], of dimers and oligomers of class A
GPCRs. Reasons for this are complex but include that
many studies have been performed without adequate
controls, that many have been limited to experiments
performed in simple transfected cell systems, and that
there are a wide range of Class A GPCRs which, although
all possessing the same general architecture of seven
linked transmembrane domains, may not all be defined
by a single pattern of structural organization or with
equivalent self-avidity. Moreover, many reported studies
are largely qualitative and have failed to address the
proportion of a receptor that might be present as dimers
or oligomers at steady-state and how this might be regu-
lated. There is also a potential issue that different tech-
niques are not equally well suited to analysis of trans-
membrane protein interactions at different levels of
expression. In physiological settings some GPCRs may
be expressed at levels of only a few hundred copies per
cell, whilst in the central nervous system some receptors
are expressed at hundreds of times this level. Covalent
interactions are not generally involved in maintaining
quaternary structure of Class A receptors. It must be
expected, therefore, that both expression levels and
intrinsic affinity will potentially determine the extent
of interactions via mass-action [4–5]. Comparisons of
outcomes for a single GPCR can illustrate the variety
of outcomes and opinions. When observed via total inter-
nal reflection fluorescence microscopy the muscarinic
acetylcholine M2 receptor (M2R) appeared to exist pre-
dominantly as a monomer but was able to reversibly form
dimers at the plasma membrane of each of transformed
Chinese Hamster Ovary cells, a cardiac cell line, primary
cardiomyocytes and tissue slices from pre-natal and post-
natal mice [6]. By contrast, fluorescence correlation spec-
troscopy (FCS) with photon counting histogram studies
reported this receptor as being organized intrinsically as a
dimer in a transfected cell line [7], whilst Fluorescence
Resonance Energy Transfer (FRET)-based approaches,
including the application of step-wise photo-bleaching
protocols, and ligand binding studies have been consis-
tent with and interpreted as showing this receptor to exist
predominantly as tetramers in both transfected cells and
native tissue [8,9]. It is challenging to bring consensus to
such varying reports. A very recent study in which the
oligomerization characteristics of three distinct class A
GPCRs, the b2-adrenoceptor (b2-AR), the cannabinoid
CB1 receptor and opsin, were investigated in proteolipo-
somes highlighted how the extent of receptor organiza-
tion is receptor type specific and sensitive towww.sciencedirect.com
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membrane curvature [10], potentially explaining some
of the disparate reports present in the literature. Although
only one subset of many approaches that have been
employed [11] methods based on Resonance Energy
Transfer (RET) techniques have been central to the
development of studies on Class A receptor quaternary
organization. Importantly, a number of recent studies
have brought the rigor of mathematics and physics to
the interpretation [10,12,13] but studies are still difficult
to transfer from either in vitro purified protein and recon-
stitution studies or the use of transfected cell systems into
more native cells and tissues. Recent times have seen a
broader palette of approaches emerge, including single
fluorescent molecule tracking studies [14,15] and analysis
of quantal brightness linked to fluorescence fluctuations
of fluorophore-tagged GPCRs [4,16].
Many GPCR homomeric complexes are
transient
Class A GPCR dimers may be transient species, at least
when present at modest levels [17,18,19] and have
shown rapid and dynamic interactions with half-times
in the second to sub second scale [19]. Single-molecule
analysis of fluorescently labelled b1-adrenoceptors and
b2-adrenoceptors indicated these were both organized as
a mixture of different sized complexes at the plasma
membrane of Chinese Hamster Ovary cells, with the
b2-AR showing higher complexity at equal expression
levels [17]. Moreover, the complexity of particularly the
b2-AR was observed to increase with receptor density at
the cell surface, consistent both with transient interac-
tions and effects of mass-action [17]. Further evidence for
transient interactions between individual protomers
being driven by mass-action has accumulated. Increasing
quaternary complexity with higher levels of expression
has also been reported via single molecule tracking of the
dopamine D2 receptor (D2R) [18,19
]. A key question in
many studies has been whether the half-life of the inter-
action between receptor protomers is modulated by the
binding of ligands to the receptor. For example, the half-
life of the interaction between unliganded D2Rs was
measured to be about 0.5 s at 24 C and although binding
of antagonists to the receptor did not alter the observed
equilibrium between monomers and dimers, the binding
of agonists did [18]. Similarly, others have measured the
half-life of the interaction between unliganded-D2R pro-
tomers to be roughly 68 ms at 37 C and, although the
addition of the antagonist UH-232 did not alter this,
treatment with either the endogenous agonist dopamine
or the synthetic agonist quinpirole stabilized dimers,
increasing the half-life to 99 and 104 ms, respectively
[19]. Although effects of ligands on GPCR dimerization
remains a contentious issue it is clearly central to fully
understand the potential significance of receptor dimers
and oligomers.www.sciencedirect.com Outcomes from fluorescence fluctuation
studies
Studies based on quantal brightness and fluorescence
fluctuation analysis have also provided support for ligand
regulation of receptor organization. The most widely used
of these methods has been Spatial Intensity Distribution
Analysis (SpIDA) [4]. Imaging of the basolateral mem-
brane of mammalian cells expressing a GPCR of interest
tagged at the intracellular carboxyl-terminal tail with a
monomeric version of a fluorescent protein such as
enhanced green fluorescent protein (mEGFP) has been
used to explore both basal organizational state of various
Class A GPCRs and the effect on this of therapeutically
relevant medicines (Figure 1). In studies on the serotonin
5-HT2C receptor (5-HT2CR), which is a target for anti-
obesity medications, at steady-state and at relatively low
density the receptor was predominantly monomeric, but
with a clearly observed fractions of dimers [20]. However,
with increasing receptor density there was a strong corre-
lation with increasing receptor organizational complexity,
and a substantial proportion of higher-order oligomers as
well as dimers was observed [20], demonstrating that the
quaternary organization of class A GPCRs is not restricted
to dimerization. A number a distinct ligand chemotypes
with affinity as 5-HT2CR antagonists acted to decrease
the complexity of organization of this receptor, essentially
converting the receptor to monomeric state [20]. Ongoing
studies have verified and extended these initial findings
(Figure 2), including for the drug ritanserin, which was
the ligand used to stabilize the 5-HT2CR for crystalliza-
tion studies [21]. This suggests that all 5-HT2CR antago-
nists may destabilize dimers and oligomers of this recep-
tor. As might be anticipated for pharmacological ligands
that bind reversibly to the target, the effect of these
compounds was concentration-dependent and following
their wash-out the initial complexity of receptor organi-
zation was fully restored [20]. Interestingly, and in con-
trast to the lack of effect of certain D2R receptor antago-
nists reported by [18], in SpIDA studies on the closely
related dopamine D3 receptor (D3R) a number of, but not
all, antagonists also promoted monomerization of the
receptor [22]. As noted earlier, [10] have recently
highlighted the effects that features such as membrane
curvature and lipid makeup can have on Class A GPCR
organization. It is important, therefore, to establish that
effects of ligands actually reflect binding of the ligand to
the receptor, rather than being produced by an off-target
effect on the membrane containing the receptor. Mar-
sango et al. [22] assessed this by generating a mutant of
the D3R that is unable to bind the antagonist spiperone.
This mutated receptor showed the same basal quaternary
organization as the wild type at equal receptor density but
now this was completely unaffected upon addition of
spiperone [22]. Initial applications of SpIDA and related
techniques highlighted the capacity to assess protein
quaternary organization from simple confocal images
and that this could be used in native tissues [16]. It isCurrent Opinion in Cell Biology 2019, 57:40–47
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Determination of receptor oligomeric structure by Spatial Intensity Distribution Analysis (SpIDA).
(a) Constructs for determination of monomeric quantal brightness: upper panel, monomeric enhanced green fluorescent protein (mEGFP) is linked
to the plasma membrane via a myristoylation/palmitoylation motif: lower panel A GPCR tagged at the intracellular C-terminal tail with mEGFP.
(b) Constructs are expressed in, for example Flp-In T-REx-293 cells, and confocal microscope images obtained.
(c) Images are opened in the SpIDA software (https://neurophotonics.ca/software), regions of interest selected and analysed for protein density
and quantal brightness.
(d) Average quantal brightness for mEGFP is determined using the myristoylation/palmitoylation-linked construct shown in (a). This generates a
value of monomeric equivalent unit.
(e) Measurements of the labelled GPCR yield an average quantal brightness value which can then be compared to the monomeric quantal
brightness to determine oligomeric organization. See [4,16] for further details.
Current Opinion in Cell Biology 2019, 57:40–47 www.sciencedirect.com
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Figure 2
0 50 100 150 200 250
0
1
2
3
4
5
6
64% dimer / oligomer
36% monomer
receptors.um-2
M
o
n
o
m
er
ic
 
eq
u
iv
al
en
t u
n
it
0 50 100 150 200 250
0
1
2
3
4
5
6
5% dimer / oligomer
95% monomer
receptors.um-2
M
o
n
o
m
er
ic
 
eq
u
iv
al
en
t u
n
it
0 50 100 150 200
0
1
2
3
4
5
6
13% dimer / oligomer
87% monomer
receptors.um
-2
M
o
n
o
m
er
ic
 
eq
ui
v
al
en
t u
n
it
0 50 100 150 200 250
0
1
2
3
4
5
6
10% dimer / oligomer
90% monomer
receptors.um-2
M
o
n
o
m
er
ic
 
eq
ui
v
al
en
t u
n
it
(a)
(b)
(c)
(d)
N
H
Me
N
MeO
H
H
N
N
N N
O
H
N
.C4H4O4
N
N
O
F3C
CH3S
.HCL
Current Opinion in Cell Biology
Effect of antagonist treatment on the serotonin 5-HT2C receptor quaternary organization.
SpIDA showing measures of individual regions of interest plotted as receptor number (density.mm2) versus monomeric equivalent units in Flp-In T-
REx-293 cells expressing 5-HT2C-mEGFP [14,20]. (a) untreated, (b), (c) and (d) Cells treated with SB-221284 (2,3-dihydro-5-(methylthio)-N-3-
pyridinyl-6-(trifluoromethyl)-1H-indole-1-carboxamide) (75 nM), SDZ SER 082 fumarate ((+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo
[1,7-bc][2,6]-naphthyridine fumarate) (5 mM) or S32212 hydrochloride (N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-1,2-dihydro-3-H-benzo[e]
www.sciencedirect.com Current Opinion in Cell Biology 2019, 57:40–47
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Table 1
Summary of approaches used to determine the molecular mechanism of protomer-protomer interaction.
Technique GPCR TMs involved in dimerization References
X-ray crystallography Adenosine A1 IV-V [38]
Biochemical approaches
Cross-linking
Gel filtration
Isolated TM addition
CCR5 chemokine
Rhodopsin
Thromboxane A2
V
I-II, IV-V
I
[39]
[40]
[30]
Biophysical approaches
BRET
FRET
Fluorescence Correlation Spectroscopy (FCS)
Pulsed-Interleaved excitation
Fluorescence Cross-Correlation Spectroscopy (FCS-FCCS)
FCS
Bimolecular Fluorescence Complementation
Rhodopsin
Angiotensin II type 1
b2-AR
Dopamine D3
Muscarinic M3
CCR5 chemokine
Cone opsins
Cone opsins
Cone opsins
b2-AR
b2-AR
I-II, IV-V
I-IV, IV-V, VI-VII
I-Helix VIII
I-II-Helix VIII, IV-V
I-II-Helix VIII-V-VI-VII
V
V
V
V
I-Helix VIII
I-Helix VIII
[40]
[41]
[29]
[23]
[42]
[39]
[28]
[28]
[28]
[29]
[29]thus likely that these types of techniques will now be
used more widely in both native tissues if appropriate
fluorophores can be attached to or incorporated into
GPCRs of interest, or in tissues isolated from transgenic
animals expressing a fluorophore-labelled GPCR.
Are specific interfaces required for
dimerization/oligomerization?
Observations of ligand effects on receptor quaternary
organization are inherently interesting but provide little
direct insight into mechanism(s). In earlier studies Mar-
sango et al. [23] had taken a mutational approach to
define potential dimerization interfaces of the D3R. This
lead to predictions of roles for both sections of trans-
membrane domain I and for amino acids in transmem-
brane domains IV and V and, therefore, indicated that
there must be multiple interfaces able to promote and
stabilize dimeric interactions. Whilst both spiperone and
haloperidol promote monomerization of the D3R they
appear to do so by different mechanisms [22]. Molec-
ular dynamics simulations of the binding of these ligands
to the D3R indicated that spiperone increased the dis-
tance between reference carbon atoms near the extra-
cellular face of transmembrane domains IV and V com-
pared to the apo-protein. By contrast, although binding
of haloperidol did not alter this distance it instead
increased the distance between reference carbon atoms
in transmembrane domains I and II [22]. By contrast
ligands such as eticlopride did not alter either of these
intra-molecular distances and also did not affect basal
receptor quaternary organization [22]. A clear conclu-
sion from these studies is that regions of each of trans-
membrane domain I and II, and domains IV and/or V,(Figure 2 Legend Continued) indole-3-carboxamide) (1 mM) respectively fo
these ligands has antagonist activity at the 5-HT2CR and was used at a con
ligand results in predominantly monomeric status of the receptor
Current Opinion in Cell Biology 2019, 57:40–47 contribute to distinct dimerization interfaces (Table 1).
It is likely that similar combinations of molecular
dynamics simulations of ligand binding and direct anal-
ysis of receptor quaternary organization will provide
further insights for other GPCRs.
Not all studies have suggested GPCR quaternary struc-
ture to be so dynamic. In studies that examined a number
of Class A receptors using FCS and photon counting
histograms [7] outcomes were interpreted as favoring
fixed dimeric organization across a substantial range of
receptor densities. This may, however simply reflect the
mean distribution observed using such ensemble-based
methods. Moreover, Wells and colleagues have consis-
tently supported a sustained, at least tetrameric, arrange-
ment for the M2R at varying receptor densities [8].
Despite these examples it now appears clear that certain
receptors have a limited ability to maintain dimeric
organization. For example, in essentially all detailed
studies the b1-adrenoceptor has acted essentially as a
monomeric protein. Similarly, SpIDA on HEK 293-
derived cells engineered to express a monomeric
eGFP-tagged form of the muscarinic M1 receptor showed
that at steady-state only a small portion of the regions of
interest examined on the basolateral membrane of these
cells contained the receptor organized predominantly as
dimers/oligomers and this was the case across expression
densities ranging from 20–120 receptor per mm2 [24]. In
this example, however, the selective M1 receptor antago-
nists pirenzepine and telenzepine increased, rather than
decreased, the level of steady-state association, although
even at concentrations of the drugs predicted to provide
full receptor occupancy this remained far fromr 24 hours. Chemical structures for each ligand are shown. Each of
centration calculated to be 10  Ki. In each case treatment with the
www.sciencedirect.com
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such as atropine did not produce this effect [24]. Recent
studies using acceptor photo-bleaching-FRET and
computational approaches, including molecular dynamics
simulations combined with multi-ensemble Markov state
models reached similar conclusions regarding the low
proportion of steady-state dimers of the m-opioid receptor
(MOR) [25].
Dimerization affects tissue function and
responsiveness
As highlighted earlier, although their overarching seven
transmembrane domain architecture might suggest con-
served interaction interfaces, protein interfaces that
encourage dimerization are still relatively poorly defined
and this area certainly lacks a single unified conclusion
[26]. Moreover, as dimer contacts frequently appear to be
transient it could be argued that no specific interface
would be dominant. Synthetic peptides derived from
specific transmembrane domains have been central to
addressing this question, and this approach recently
translated from in vitro to in vivo studies that indicated
a key role for transmembrane domain I in interactions
between rhodopsin protomers [27]. Alternatively, how-
ever, a mutagenic approach instead suggested a key role
for transmembrane domain V residues in human red cone
opsin [28]. Moreover, assuming that a significant fraction
of the b2-AR can indeed exist as dimers, transmembrane
domain I may play an integral role [29]. This is also the
case for the thromboxane A2 receptor [30
] and, intrigu-
ingly in the context of physiology and disease, patients
with mutations in this region of the receptor that show
reduced dimerization in in vitro studies have also been
shown to suffer bleeding disorders associated with
reduced platelet function [30]. This provides a poten-
tially key link between poor dimerization capability and
reduced receptor function in vivo and, therefore, a patho-
physiological significance of Class A GPCR dimerization.
Studies on other GPCRs have implicated other trans-
membrane domains. For the angiotensin AT1 receptor,
each of domains IV, V, VI, and VII were recently impli-
cated [31]. Clearly such differences in results may reflect
different modes of interaction, or indeed that different
interfaces are required to construct dimers, trimers, and
tetramers, for example [32] as there is now less of a
consensus that quaternary organization must be built in
monomer-dimer-tetramer-octamer like multiples
[10,32]. Although a class B GPCR, studies on the
secretin receptor identified a key role for transmembrane
domain IV and here mutation of a pair of amino acids in
the middle of this domain was originally suggested to
convert the receptor from strict dimer to monomer. This
is associated with altered capacity of the agonist secretin
to stimulate levels of cyclic AMP. Recent SpIDA-based
studies have supported the idea that these specific muta-
tions do substantially reduce the propensity of this recep-
tor to form a dimeric complex but added a degree ofwww.sciencedirect.com further subtlety in suggesting that these mutants modu-
late the propensity for rather than define a strict monomer
to dimer transition [33]. Of course there is no inherent
requirement that direct protein-protein interactions
define dimeric or oligomeric Class A GPCR organization.
Recent cryo-electron microscopy experiments performed
on purified 5-HT2A receptor in the presence or absence of
molecules of cholesterol were interpreted to show that
this receptor was able to form dimers in the presence of
cholesterol while, in contrast, it existed only as a mono-
mer when cholesterol was removed [34]. The importance
of molecules of cholesterol in determining the oligomeri-
zation state of GPCRs has also been highlighted in
studies using photo-bleaching image correlation spectros-
copy on the serotonin 5-HT1A receptor [35]. Whilst a
trimeric population of the 5-HT1A receptor was prevalent
in normal cell membranes, depletion of cholesterol
appeared to favor the dimeric state of this receptor
[35]. As addressed directly by [10], others have also
suggested that the lipid composition of plasma membrane
could also influence the stability and the mechanism of
formation of the quaternary structures of GPCRs [36] and
that different cell types might produce different out-
comes based on this feature. Moreover, combined model-
ling and mutagenesis studies were used to predict-spe-
cific roles of molecules of cholesterol in stabilizing a
tetrameric configuration of the D3R [22
] whilst compu-
tational studies also predict roles of cholesterol in dimer-
ization of a broad range of chemokine receptors [37].
Conclusions
Many Class A GPCRs are able to form dimers and
oligomers. Although this may be transient in many situa-
tions, at physiological expression levels dimer and oligo-
mers may represent a substantial population. Growing
data indicate the extent and kinetics of such quaternary
complexes are regulated by ligand binding and this may
have marked significance for the action of therapeutic
medicines.
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